George Doumat
georgedoumat.bsky.social
George Doumat
@georgedoumat.bsky.social
PGY1 at UTSW IM | Previous Research Fellow at Mass General | MD 22’ AUBMC | Interested in Pulmonology & Critical Care 🫁
#medsky
Had a blast recording with the @pulmpeeps.bsky.social! Exciting times ahead as incredible science drives new advances in #bronchiectasis.
New episode out today!! We're back with BMJ Thorax to review high yield articles about bronchiectasis. We'll discuss new and emerging treatment options, and cohort studies on etiologies and quality of life. Listen wherever you get your podcasts or at www.pulmpeeps.com
October 7, 2025 at 10:54 PM
Reposted by George Doumat
Thorax Podcast - Bronchiectasis, with the PulmPEEPs
▶️ Apple: podcasts.apple.com/us/podcast/b...
▶️ Spotify: open.spotify.com/episode/27Uf...
▶️ Web: thoraxbmj.podbean.com/e/thorax-pod... @bmj.com #LungSky #RespEd
Bronchiectasis, with the PulmPEEPs
Podcast Episode · Thorax Podcast · 10/07/2025 · 37m
podcasts.apple.com
October 7, 2025 at 1:19 PM
Reposted by George Doumat
Is there a better thing for a physician scientist than to have an impact on our patients - to take a previously ignored and hopeless disease and make it treatable?
Kudos Prof Chalmers ! What an amazing achievment!!! also 👏🏼to all #Aspen investigators 👏🏼
#CureBronchoiectasis
#ScienceMatters
Phase 3 Trial of the DPP-1 Inhibitor Brensocatib in Bronchiectasis | NEJM
In bronchiectasis, neutrophilic inflammation is associated with an increased risk of exacerbations and disease progression. Brensocatib, an oral, reversible inhibitor of dipeptidyl peptidase 1 (DPP...
www.nejm.org
April 25, 2025 at 10:09 PM
🚨 Excited to share our latest work to start off 2025! Our chapter "Invasive Pulmonary Aspergillosis in Other Patient Populations" is now published! 🦠📚 A closer look at this challenging condition in diverse patient groups.

Read more here:

link.springer.com/chapter/10.1...
Invasive Pulmonary Aspergillosis in Other Patient Populations
Invasive pulmonary aspergillosis (IPA) is increasingly reported in patients with non-classic host factors, including those with liver and lung diseases, solid malignancies, human immunodeficiency viru...
link.springer.com
January 4, 2025 at 12:24 AM
Reposted by George Doumat
#PCCMSky Update

Up to 95 members

Repost so those new to this place can populate their following list with good PCCM people

Reply if you are not on this list and should be

go.bsky.app/88wg6oG
November 21, 2024 at 1:49 PM
November 17, 2024 at 10:55 PM
Reposted by George Doumat
For the new BlueSky members who have left #ILDTwitter I’ve updated this starter-pack to help you find key ILD and ILD-adjacent community members here. Pls comment if I’ve missed you and I’ll add you 🫁😊
#CurePF #CureIPF #ILD

go.bsky.app/8u4KcNo
November 14, 2024 at 3:22 AM
Reposted by George Doumat
The real barriers to meaningful research aren’t lack of ideas, enthusiastic participants, driven scientists - they’re academic legal, REB, and administrative delays.

I’ve been told to build relationships with these teams but there’s so much turnover, it’s like every project is the 1st. Ideas?
a man says come up with new ideas in front of a big think logo
Alt: Bill Nye the science guy says come up with new ideas in front of a big think logo
media.tenor.com
November 12, 2024 at 11:49 PM
Reposted by George Doumat
Starter Packs are fascinating windows into who is on here, who puts themselves out there, and who is considered worth listening to — perhaps overweighted to the last

A reminder that ICU 🩺🧪 medicine science are still far too white, too male too straight

We got work to do. Elevate new voices, please
November 10, 2024 at 7:33 PM